Glecaprevir/Pibrentasvir (Mavyret) for the Treatment of Chronic Hepatitis C

Am Fam Physician. 2018 Nov 15;98(10):601-602.

Authors

Anupriya Grover¹, Deborah R Erlich²

Affiliations

¹ Cambridge Health Alliance, Malden, MA, USA.
² Tufts University School of Medicine and Harvard Medical School, Boston, MA, USA.

PMID: 30365290

No abstract available

MeSH terms

Aminoisobutyric Acids
Antiviral Agents / administration & dosage*
Antiviral Agents / economics
Benzimidazoles / administration & dosage*
Benzimidazoles / economics
Cyclopropanes
Drug Combinations
Hepatitis C, Chronic / drug therapy*
Humans
Lactams, Macrocyclic
Leucine / analogs & derivatives
Proline / analogs & derivatives
Pyrrolidines
Quinoxalines / administration & dosage*
Quinoxalines / economics
Sulfonamides / administration & dosage*
Sulfonamides / economics

Substances

Aminoisobutyric Acids
Antiviral Agents
Benzimidazoles
Cyclopropanes
Drug Combinations
Lactams, Macrocyclic
Pyrrolidines
Quinoxalines
Sulfonamides
pibrentasvir
Proline
Leucine
glecaprevir